As a recognized world leader in pluripotent stem cell banking and characterization, WiCell provides the stem cell community with high-quality cell lines as well as accurate and reliable cell characterization and cytogenetic testing services. The WiCell Stem Cell Bank provides a diverse range of human pluripotent stem cell lines, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), disease models, genetically modified variants, and cGMP grade cell lines. Our characterization services include non-GMP and cGMP karyotyping, Fluorescence in situ Hybridization (FISH), and authentication via Short Tandem Repeat (STR) profiling. In addition, we offer non-GMP Single Nucleotide Polymorphism (SNP) microarray and mycoplasma testing. Long-term liquid nitrogen storage is available through our WiCellSAFE program and tailored services like quality control testing and contract cell banking, designed to help laboratories maximize their resources efficiently, are also available through WiCell. 
 
At WiCell, our mission extends beyond providing high-quality stem cell lines and characterization services. We are dedicated to advancing regenerative medicine and cell and gene therapy globally. Through promoting best practices in cell banking and characterization, we aim to support groundbreaking research and clinical applications. Our efforts are rooted in a commitment to quality, innovation, and collaboration, reflecting our history of pioneering stem cell technology since 1999. This commitment underscores our desire to support the scientific community as your lab partner.